The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The Epstein–Barr nuclear antigen 3 (EBNA3) family of proteins, comprising EBNA3A, EBNA3B, and EBNA3C, play pivotal roles in the asymptomatic persistence and life-long latency of Epstein–Barr virus (EBV) in the worldwide human population. EBNA3-mediated transcriptional reprogramming of numerous host cell genes promotes in vitro B cell transformation and EBV persistence in vivo. Despite structural and sequence similarities, and evidence of substantial cooperative activity between the EBNA3 proteins, they perform quite different, often opposing functions. Both EBNA3A and EBNA3C are involved in the repression of important tumour suppressive pathways and are considered oncogenic. In contrast, EBNA3B exhibits tumour suppressive functions. This review focuses on how the EBNA3 proteins achieve the delicate balance required to support EBV persistence and latency, with emphasis on the contribution of the Allday laboratory to the field of EBNA3 biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“EBNA3C plays a central function to restrain transcription of p16INK4a in these cells as suggested previously [23–25].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [23]
In the citing paper
“In the absence of EBNA3C, cells expressing p16INK4a are lost because they enter a G1 block and thus cease to proliferate as suggested previously, for a recent review see [23].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [23]
In the citing paper
“which reportedly blocked proliferation of latently EBV-infected B cells in the absence of EBNA3C’s repressive epigenetic functions [23–25].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596 · cited 8×
“In addition to p15INK4b and p16INK4a, EBNA3A and EBNA3C have also been shown to repress the INK4 family member p18INK4c through PRC2-mediated deposition of H3K27me3 ([13]).”
BackgroundInfluentialEnders, A., Bouillet, P., Puthalakath, H., Xu, Y., Tarlinton, D. M., & Strasser, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030411 · Cited by 295
Epigenetic regulation of the INK4b-ARF-INK4a locus: In sickness and in health
Popov, N., & Gil, J. (2010) · Epigenetics · doi:10.4161/epi.5.8.12996 · Cited by 202 · cited 2×
“This gene encodes the related INK4 family protein p15INK4b, which performs similar functions to p16INK4a [55].”
Background
Research works printed but not linked: 80
- Klein, 2002, Perspectives in studies of human tumor viruses, Front. Biosci., 7, d268, 10.2741/klein · doi:10.2741/klein
- Young, 2004, Epstein-Barr virus: 40 years on, Nat. Rev. Cancer, 4, 757, 10.1038/nrc1452 · DOI · Paper page
- Roughan, 2009, The intersection of Epstein-Barr virus with the germinal center, J. Virol., 83, 3968, 10.1128/JVI.02609-08 · doi:10.1128/jvi.02609-08
- Yenamandra, 2009, Comparative analysis of the Epstein-Barr virus encoded nuclear proteins of EBNA-3 family, Comput. Biol. Med., 39, 1036, 10.1016/j.compbiomed.2009.08.006 · DOI
- Kerdiles, 1994, The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter, Virology, 205, 596, 10.1006/viro.1994.1687 · doi:10.1006/viro.1994.1687
- Touitou, 2005, Epstein-Barr virus EBNA3 proteins bind to the c8/alpha7 subunit of the 20s proteasome and are degraded by 20s proteasomes in vitro, but are very stable in latently infected B cells, J. Gen. Virol., 86, 1269, 10.1099/vir.0.80763-0 · DOI
- Davies, 2010, Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines, Virology, 400, 53, 10.1016/j.virol.2010.01.002 · DOI
- White, R.E., Groves, I.J., Turro, E., Yee, J., Kremmer, E., and Allday, M.J. (2010). Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification. PLoS ONE, 5. · DOI
- Anderton, 2008, Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor BIM: Clues to the pathogenesis of Burkitt’s lymphoma, Oncogene, 27, 421, 10.1038/sj.onc.1210668 · DOI · Paper page
- Skalska, L., White, R.E., Franz, M., Ruhmann, M., and Allday, M.J. (2010). Epigenetic repression of p16(INK4a) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog., 6. · DOI · Paper page
- Maruo, 2006, Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells, Proc. Natl. Acad. Sci. USA, 103, 19500, 10.1073/pnas.0604919104 · DOI · Paper page
- Bazot, Q., Paschos, K., Skalska, L., Kalchschmidt, J.S., Parker, G.A., and Allday, M.J. (2015). Epstein-Barr virus proteins EBNA3A and EBNA3C together induce expression of the oncogenic microRNA cluster miR-221/miR-222 and ablate expression of its target p57KIP2. PLoS Pathog., 11. · DOI
- Styles, C.T., Bazot, Q., Parker, G.A., White, R.E., Paschos, K., and Allday, M.J. (2017). EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency. PLoS Biol., 15. · DOI · Paper page
- Maruo, 2003, Epstein-Barr virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth, J. Virol., 77, 10437, 10.1128/JVI.77.19.10437-10447.2003 · doi:10.1128/jvi.77.19.10437-10447.2003
- Paschos, 2012, BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV, Nucleic Acids Res., 40, 7233, 10.1093/nar/gks391 · DOI
- Jiang, 2014, Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits SIN3A to repress CDKN2A, Proc. Natl. Acad. Sci. USA, 111, 421, 10.1073/pnas.1321704111 · DOI
- Schmidt, 2015, Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes, Proc. Natl. Acad. Sci. USA, 112, 554, 10.1073/pnas.1422580112 · DOI
- Paschos, 2016, Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression, Nucl. Acids Res., 45, 2368, 10.1093/nar/gkw1167 · DOI
- Parker, 1996, Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7, Oncogene, 13, 2541
- Allday, 2015, The EBNA3 family: Two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells, Curr. Top. Microbiol. Immunol., 391, 61
- Lee, 1999, Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus, J. Virol., 73, 2974, 10.1128/JVI.73.4.2974-2982.1999 · DOI
- Cohen, 1989, Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation, Proc. Natl. Acad. Sci. USA, 86, 9558, 10.1073/pnas.86.23.9558 · DOI · Paper page
- Tomkinson, 1993, Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation, J. Virol., 67, 2014, 10.1128/jvi.67.4.2014-2025.1993 · DOI · Paper page
- Kaye, 1993, Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation, Proc. Natl. Acad. Sci. USA, 90, 9150, 10.1073/pnas.90.19.9150 · DOI · Paper page
- Mannick, 1991, The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation, J. Virol., 65, 6826, 10.1128/jvi.65.12.6826-6837.1991 · DOI · Paper page
- Hertle, M.L., Popp, C., Petermann, S., Maier, S., Kremmer, E., Lang, R., Mages, J., and Kempkes, B. (2009). Differential gene expression patterns of EBV infected EBNA-3A positive and negative human b lymphocytes. PLoS Pathog., 5. · DOI
- White, 2012, EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors, J. Clin. Invest., 122, 1487, 10.1172/JCI58092 · DOI · Paper page
- Robertson, 1996, The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa), J. Virol., 70, 3068, 10.1128/jvi.70.5.3068-3074.1996 · doi:10.1128/jvi.70.5.3068-3074.1996
- Robertson, 1995, Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa, J. Virol., 69, 3108, 10.1128/jvi.69.5.3108-3116.1995 · DOI · Paper page
- Kalchschmidt, J.S., Gillman, A.C., Paschos, K., Bazot, Q., Kempkes, B., and Allday, M.J. (2016). EBNA3C directs recruitment of RBPJ (CBF1) to chromatin during the process of gene repression in EBV infected B cells. PLoS Pathog., 12. · DOI
- Zhao, 1996, A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of J kappa, J. Virol., 70, 4228, 10.1128/jvi.70.7.4228-4236.1996 · DOI
- West, 2017, Chromatin reorganisation in Epstein-Barr virus-infected cells and its role in cancer development, Curr. Opin. Virol., 26, 149, 10.1016/j.coviro.2017.08.004 · DOI
- Johannsen, 1996, EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes, J. Virol., 70, 4179, 10.1128/jvi.70.6.4179-4183.1996 · doi:10.1128/jvi.70.6.4179-4183.1996
- Radkov, 1997, Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21, J. Virol., 71, 8552, 10.1128/jvi.71.11.8552-8562.1997 · DOI
- Maruo, 2005, Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: Transcriptional regulation through RBP-jkappa/CBF1 is critical, J. Virol., 79, 10171, 10.1128/JVI.79.16.10171-10179.2005 · DOI
- Maruo, 2009, Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth, Proc. Natl. Acad. Sci. USA, 106, 4419, 10.1073/pnas.0813134106 · doi:10.1073/pnas.0813134106
- Lee, 2009, Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: Interaction with RBP-Jkappa regulates TCL1, J. Virol., 83, 12368, 10.1128/JVI.01403-09 · DOI
- McClellan, M.J., Wood, C.D., Ojeniyi, O., Cooper, T.J., Kanhere, A., Arvey, A., Webb, H.M., Palermo, R.D., Harth-Hertle, M.L., and Kempkes, B. (2013). Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming. PLoS Pathog., 9. · DOI
- Wang, 2015, Epstein-Barr virus nuclear antigen 3 (EBNA3) proteins regulate EBNA2 binding to distinct RBPJ genomic sites, J. Virol., 90, 2906, 10.1128/JVI.02737-15 · DOI
- Harth-Hertle, M.L., Scholz, B.A., Erhard, F., Glaser, L.V., Dölken, L., Zimmer, R., and Kempkes, B. (2013). Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog., 9. · DOI
- Wood, C.D., Veenstra, H., Khasnis, S., Gunnell, A., Webb, H.M., Shannon-Lowe, C., Andrews, S., Osborne, C.S., and West, M.J. (2016). MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. eLife, 5. · DOI · Paper page
- Skalska, L., White, R.E., Parker, G.A., Turro, E., Sinclair, A.J., Paschos, K., and Allday, M.J. (2013). Induction of p16(INK4a) is the major Barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog., 9. · DOI
- Hickabottom, 2002, Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP), J. Biol. Chem., 277, 47197, 10.1074/jbc.M208116200 · DOI
- Knight, 2003, Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSIN3A and NCoR in human B-cell lines, J. Virol., 77, 4261, 10.1128/JVI.77.7.4261-4272.2003 · DOI
- Radkov, 1999, Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription, J. Virol., 73, 5688, 10.1128/JVI.73.7.5688-5697.1999 · DOI
- Touitou, 2001, Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C, J. Virol., 75, 7749, 10.1128/JVI.75.16.7749-7755.2001 · DOI
- Cotter, 2000, Modulation of histone acetyltransferase activity through interaction of Epstein-Barr nuclear antigen 3C with prothymosin alpha, Mol. Cell. Biol., 20, 5722, 10.1128/MCB.20.15.5722-5735.2000 · DOI
- Kalchschmidt, 2016, Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells, J. Exp. Med., 213, 921, 10.1084/jem.20160120 · DOI
- Frangini, 2013, The aurora B kinase and the polycomb protein Ring1b combine to regulate active promoters in quiescent lymphocytes, Mol. Cell, 51, 647, 10.1016/j.molcel.2013.08.022 · DOI
- McClellan, 2012, Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements, J. Virol., 86, 5165, 10.1128/JVI.07161-11 · doi:10.1128/jvi.07161-11
- Bazot, Q., Paschos, K., and Allday, M.J. (2018). Epstein-Barr virus latent protein EBNA3A directly targets and silences the kinase STK39 in B cells infected by EBV. J. Virol. · DOI
- Allday, 2013, EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection, Front. Genet., 4, 212, 10.3389/fgene.2013.00212 · DOI
- Maruo, 2011, Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4a and p14ARF expression, Proc. Natl. Acad. Sci. USA, 108, 1919, 10.1073/pnas.1019599108 · DOI
- Chinnadurai, 2009, The transcriptional corepressor CtBP: A foe of multiple tumor suppressors, Cancer Res., 69, 731, 10.1158/0008-5472.CAN-08-3349 · DOI · Paper page
- Bazot, 2014, Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1, Nucleic Acids Res., 42, 9700, 10.1093/nar/gku697 · DOI
- Jiang, 2017, The Epstein-Barr virus regulome in lymphoblastoid cells, Cell Host Microbe, 22, 561, 10.1016/j.chom.2017.09.001 · DOI
- Banerjee, S., Lu, J., Cai, Q., Sun, Z., Jha, H.C., and Robertson, E.S. (2014). EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation. PLoS Pathog., 10. · DOI
- Tursiella, M.L., Bowman, E.R., Wanzeck, K.C., Throm, R.E., Liao, J., Zhu, J., and Sample, C.E. (2014). Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. PLoS Pathog., 10. · DOI
- Strasser, 2005, The role of BH3-only proteins in the immune system, Nat. Rev. Immunol., 5, 189, 10.1038/nri1568 · DOI · Paper page
- Fischer, 2007, Proapoptotic BH3-only protein BIM is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells, Blood, 110, 3978, 10.1182/blood-2007-05-091306 · DOI · Paper page
- Dang, 2005, The great MYC escape in tumorigenesis, Cancer Cell, 8, 177, 10.1016/j.ccr.2005.08.005 · DOI
- Egle, 2004, BIM is a suppressor of MYC-induced mouse B cell leukemia, Proc. Natl. Acad. Sci. USA, 101, 6164, 10.1073/pnas.0401471101 · DOI · Paper page
- Paschos, K., Smith, P., Anderton, E., Middeldorp, J.M., White, R.E., and Allday, M.J. (2009). Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene BIM. PLoS Pathog., 5. · DOI · Paper page
- Allday, 2008, The curious case of the tumour virus: 50 years of Burkitt’s lymphoma, Nat. Rev. Microbiol., 6, 913, 10.1038/nrmicro2015 · DOI · Paper page
- Nikitin, 2010, An ATM/CHK2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells, Cell Host Microbe, 8, 510, 10.1016/j.chom.2010.11.004 · DOI · Paper page
- Saha, 2009, Epstein-Barr virus nuclear antigen 3C augments MDM2-mediated p53 ubiquitination and degradation by deubiquitinating MDM2, J. Virol., 83, 4652, 10.1128/JVI.02408-08 · DOI
- Yi, 2009, Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities, Virology, 388, 236, 10.1016/j.virol.2009.03.027 · DOI
- Jha, 2014, Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression, J. Virol., 88, 3776, 10.1128/JVI.03568-13 · DOI
- Knight, 2005, Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase, Proc. Natl. Acad. Sci. USA, 102, 18562, 10.1073/pnas.0503886102 · DOI · Paper page
- Saha, A., Lu, J., Morizur, L., Upadhyay, S.K., Aj, M.P., and Robertson, E.S. (2012). E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells. PLoS Pathog., 8. · DOI
- Knight, 2004, Epstein-Barr virus nuclear antigen 3C regulates cyclin a/p27 complexes and enhances cyclin a-dependent kinase activity, J. Virol., 78, 1981, 10.1128/JVI.78.4.1981-1991.2004 · DOI
- Knight, 2005, Scfskp2 complex targeted by Epstein-Barr virus essential nuclear antigen, Mol. Cell. Biol., 25, 1749, 10.1128/MCB.25.5.1749-1763.2005 · DOI
- Bajaj, 2008, Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-MYC oncoprotein, J. Virol., 82, 4082, 10.1128/JVI.02500-07 · DOI
- Tomkinson, 1992, Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro, J. Virol., 66, 2893, 10.1128/jvi.66.5.2893-2903.1992 · doi:10.1128/jvi.66.5.2893-2903.1992
- Gagrica, 2012, Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence, Cancer Res., 72, 165, 10.1158/0008-5472.CAN-11-2552 · DOI
- Morse, 1997, Induction of cell cycle arrest and B cell terminal differentiation by cdk inhibitor p18(INK4c) and il-6, Immunity, 6, 47, 10.1016/S1074-7613(00)80241-1 · DOI · Paper page
- Tourigny, 2002, Cdk inhibitor p18(INK4c) is required for the generation of functional plasma cells, Immunity, 17, 179, 10.1016/S1074-7613(02)00364-3 · DOI
- Boi, 2015, PRDM1/BLIMP1: A tumor suppressor gene in B and T cell lymphomas, Leuk. Lymphoma, 56, 1223, 10.3109/10428194.2014.953155 · DOI
- Mandelbaum, 2010, BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma, Cancer Cell, 18, 568, 10.1016/j.ccr.2010.10.030 · DOI · Paper page
- Minnich, 2016, Multifunctional role of the transcription factor BLIMP-1 in coordinating plasma cell differentiation, Nat. Immunol., 17, 331, 10.1038/ni.3349 · DOI · Paper page
Cited by
Farrell, P. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013023 · Cited by 541
Self-citationLatency and lytic replication in Epstein–Barr virus-associated oncogenesis
Münz, C. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0249-7 · Cited by 469
Cohen, J. I. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136225 · Cited by 280
Akidil, E., Albanese, M., Buschle, A., Ruhle, A., Pich, D., Keppler, O. T., & Hammerschmidt, W. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009117 · Cited by 31
Metadata
- Authors
- Styles, C., Paschos, K., White, R., & Farrell, P.
- Affiliations
- Molecular Virology, Department of Medicine, Imperial College London, London W2 1PG, UK
- ORCID
- Styles, Christine
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2018-03-17
- Volume
- 7
- Issue
- 1
- Pages
- 31
- ISSN
- 2076-0817
- Cited by
- 41
- References
- 3
- Language
- en
- Funders
- Wellcome Trust (099273/Z/12/Z)
- MRC (G01362)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.